Show simple item record

dc.contributor.authorMurphy, Emma J.
dc.contributor.authorRezoagli, Emanuele
dc.contributor.authorCollins, Catherine
dc.contributor.authorKumar Saha, Sushanta
dc.contributor.authorMajor, Ian
dc.contributor.authorMurray, Patrick
dc.date.accessioned2023-07-11T11:01:57Z
dc.date.available2023-07-11T11:01:57Z
dc.date.copyright2023
dc.date.issued2023-06-05
dc.identifier.citationMurphy, E. J., Rezoagli, E., Collins, C., Kumar Saha, S., Major, I. and Murray, P. (2023) Sustainable production and pharmaceutical applications of β-glucan from microbial sources, Microbiological Research, 274(127424), pp. 1-16. https://doi.org/10.3390/ pharmaceutics15010200en_US
dc.identifier.issn0944-5013
dc.identifier.urihttps://research.thea.ie/handle/20.500.12065/4564
dc.description.abstractβ-glucans are a large class of complex polysaccharides found in abundant sources. Our dietary sources of β-glucans are cereals that include oats and barley, and non-cereal sources can consist of mushrooms, microalgae, bacteria, and seaweeds. There is substantial clinical interest in β-glucans; as they can be used for a variety of diseases including cancer and cardiovascular conditions. Suitable sources of β-glucans for biopharmaceutical applications include bacteria, microalgae, mycelium, and yeast. Environmental factors including culture medium can influence the biomass and ultimately β-glucan content. Therefore, cultivation conditions for the above organisms can be controlled for sustainable enhanced production of β-glucans. This review discusses the various sources of β-glucans and their cultivation conditions that may be optimised to exploit sustainable production. Finally, this article discusses the immune-modulatory potential of β-glucans from these sources.en_US
dc.formatapplication/pdfen_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.relation.ispartofMicrobiological Researchen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectβ-glucanen_US
dc.subjectMicro-algaeen_US
dc.subjectYeasten_US
dc.subjectFungien_US
dc.subjectBacteriaen_US
dc.subjectImmune-modulationen_US
dc.titleSustainable production and pharmaceutical applications of β-glucan from microbial sourcesen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.contributor.affiliationTechnological University of the Shannon: Midlands Midwesten_US
dc.description.peerreviewyesen_US
dc.identifier.doihttps://doi.org/10.1016/j.micres.2023.127424en_US
dc.identifier.endpage16en_US
dc.identifier.orcidhttps://orcid.org/0000-0002-5620-0058 View this author’s ORCID profileen_US
dc.identifier.orcidhttps://orcid.org/0000-0002-4506-7212en_US
dc.identifier.orcidhttps://orcid.org/0000-0002-3981-8833en_US
dc.identifier.orcidhttps://orcid.org/0000-0002-0538-9786en_US
dc.identifier.orcidhttps://orcid.org/0000-0001-6349-7761en_US
dc.identifier.startpage1en_US
dc.identifier.volume274en_US
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessen_US
dc.subject.departmentLIFE–Health and Biosciences Research Instituteen_US
dc.type.versioninfo:eu-repo/semantics/publishedVersionen_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's license is described as Attribution 4.0 International